Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CQS in Stage IV Colorectal Cancer
NCT00005864Phase 2Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Apr 2000
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of chlorsulfaquinoxaline in colorectal cancer (CRC), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Started Apr 2000; status: completed.
02
Drugs
chlorsulfaquinoxaline
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00005864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005864.